Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents.
暂无分享,去创建一个
W. Wijns | G. Patti | E. Barbato | B. De Bruyne | A. Peace | G. Di Gioia | F. Mangiacapra | E. Ricottini | G. Di Sciascio
[1] S. Silber,et al. The influence of age on clinical outcomes in patients treated with the resolute zotarolimus‐eluting stent , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[2] J. Wójcik,et al. 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. , 2015, Journal of the American College of Cardiology.
[3] Antonio Colombo,et al. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. , 2014, Journal of the American College of Cardiology.
[4] Helmut Baumgartner,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] N. Curzen,et al. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly). , 2014 .
[6] A. Kastrati,et al. Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] J. Wójcik,et al. Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial , 2014 .
[8] W. Wijns,et al. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. , 2013, Archives of cardiovascular diseases.
[9] G. Stone,et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. , 2013, Journal of the American College of Cardiology.
[10] P. Serruys,et al. Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[11] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[12] G. Stone,et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis , 2012, The Lancet.
[13] K. Anstrom,et al. Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States. , 2012, Journal of the American College of Cardiology.
[14] W. Wijns,et al. Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting. , 2011, American heart journal.
[15] Michael P. Thomas,et al. Outcome of Contemporary Percutaneous Coronary Intervention in the Elderly and the Very Elderly: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium , 2011, Clinical cardiology.
[16] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[17] P. Serruys,et al. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). , 2010, The American journal of cardiology.
[18] J. Pell,et al. Percutaneous Coronary Intervention in the Elderly: Changes in Case-Mix and Periprocedural Outcomes in 31 758 Patients Treated Between 2000 and 2007 , 2010, Circulation. Cardiovascular interventions.
[19] G. Biondi-Zoccai,et al. A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions , 2009, Acta cardiologica.
[20] W. Ghali,et al. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? , 2008, International journal of cardiology.
[21] R. Costa,et al. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry. , 2008, The Journal of invasive cardiology.
[22] F. Eberli,et al. Age‐Related Differences in the Use of Guideline‐Recommended Medical and Interventional Therapies for Acute Coronary Syndromes: A Cohort Study , 2008, Journal of the American Geriatrics Society.
[23] Terry M Therneau,et al. Coronary revascularization in the community. A population-based study, 1990 to 2004. , 2007, Journal of the American College of Cardiology.
[24] M. Naylor,et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.
[25] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[26] I. Seong,et al. Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease , 2006, Circulation.
[27] Harlan M. Krumholz,et al. Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry , 2006, Circulation.
[28] K. Alexander,et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. , 2005, Journal of the American College of Cardiology.
[29] F. Fernández‐Avilés,et al. Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial , 2005, Circulation.
[30] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[31] K. Anstrom,et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. , 2000, Journal of the American College of Cardiology.